Meghan Adams

Meghan Adams assists the Biotechnology Group in patent prosecution. She has extensive knowledge in the areas of molecular biology, imaging, cell sorting, microinjection and other types of embryological manipulation.

Recent Posts

Avoid Ulcers by Crafting a Well-Reasoned Petition

Posted by Meghan Adams on Apr 13, 2017

Meghan Adams

Your IPR petition argues that a patent is obvious—but will those arguments even be fully considered? A recent decision in Affordable Drugs VII v. Pozen Inc. emphasizes the importance of providing evidence-based arguments within the appropriate documents that inform the Board’s investigation.

Read More

Topics: Kyle Bass, Biotech

Wolf Greenfield's Post-Grant Blog

Here, the Post-Grant Proceedings Group
at Wolf Greenfield keeps you up to date
on the latest decisions and best practices, and what they mean for you. Learn more about the group and its members.

New Call-to-action
New Call-to-action
New Call-to-action

Subscribe to Email Updates

Follow Us

This blog is intended to promote thought and debate on developing areas of the law. The opinions, commentary and characterizations of cases provided on this blog are not legal advice and do not represent the opinions of Wolf Greenfield or its clients.